| Literature DB >> 23067573 |
Courtney Lee1, Cindy Crawford, Dawn Wallerstedt, Alexandra York, Alaine Duncan, Jennifer Smith, Meredith Sprengel, Richard Welton, Wayne Jonas.
Abstract
BACKGROUND: Co-morbid symptoms (for example, chronic pain, depression, anxiety, and fatigue) are particularly common in military fighters returning from the current conflicts, who have experienced physical and/or psychological trauma. These overlapping conditions cut across the boundaries of mind, brain and body, resulting in a common symptomatic and functional spectrum of physical, cognitive, psychological and behavioral effects referred to as the 'Trauma Spectrum Response' (TSR). While acupuncture has been shown to treat some of these components effectively, the current literature is often difficult to interpret, inconsistent or of variable quality. Thus, to gauge comprehensively the effectiveness of acupuncture across TSR components, a systematic review of reviews was conducted using the Samueli Institute's Rapid Evidence Assessment of the Literature (REAL©) methodology.Entities:
Mesh:
Year: 2012 PMID: 23067573 PMCID: PMC3534620 DOI: 10.1186/2046-4053-1-46
Source DB: PubMed Journal: Syst Rev ISSN: 2046-4053
Figure 1Trauma spectrum response.
PubMed search strategy and keyword definitions
| Chronic pain | Acupuncture AND (“pain”[Mesh] OR “pain” OR “chronic pain” OR “back pain”[Mesh] OR “facial neuralgia”[Mesh] OR “prostatitis”[Mesh] OR “fibromyalgia”[Mesh] OR “back pain*” OR “facial neuralgia*” OR “prostatitis” OR “fibromyalgia”) | defined as any condition included in the American Chronic Pain Association’s list of chronic conditions, or any type of pain lasting longer than three months |
| Substance abuse | Acupuncture AND (“substance-related disorders”[Mesh] OR “substance-related disorder” OR “drug dependence” OR “substance abuse”) | any drug or chemical abuse, dependence or addiction |
| Sleep disturbance | Acupuncture AND (“Sleep Disorders"[Mesh] OR “sleep disorder*”) | insomnia, narcolepsy, hyperarousal, sleep apnea |
| Depression | Acupuncture AND (“Depression”[Mesh] OR “Depressive Disorder”[Mesh] OR depression* OR “depressive disorder*”) | substance-induced mood disorder and major, chronic, bipolar, seasonal, psychotic, postpartum, double, secondary, chronic treatment-resistant, and masked depressions |
| Headache | Acupuncture AND (“Headache”[Mesh] OR “Headache Disorders”[Mesh] OR “headache*” OR “headache disorder*” OR “post-traumatic headache*”[Mesh] OR “post-concussive headache*” OR “post-concussive syndrome*” OR “TBI headache*”) | headache of any etiology and duration |
| Anxiety | Acupuncture AND (“Anxiety Disorders”[Mesh] OR “dental anxiety”[Mesh] OR “catastrophization”[Mesh] OR “anxiety disorder*” OR “anxiety”) | dissociative anxiety, generalized anxiety disorder, panic disorder, phobic disorder, obsessive compulsive disorder |
| Cognitive function | Acupuncture AND (“memory”[Mesh] OR “cognition”[Mesh] OR “memor*” OR “cognition*” OR “problem solving” OR “attention” OR “concentration”) | attention, concentration, memory, perception, and problem solving difficulties as well dementia, autism, attention deficit disorder, stroke |
| Fatigue | Acupuncture AND (“fatigue”[Mesh]) | any type of fatigue |
| PTSD | Acupuncture AND (“Stress Disorders, Traumatic”[Mesh] or “post-traumatic stress disorder” OR “ptsd”) | any type of traumatic stress disorder |
| Sexual function | Acupuncture AND (“sexual function*” OR “sexual dysfunction*”) | any type of sexual function disorder |
akeywords were searched using Mesh terms and automatic term mapping.
Figure 2Flow chart of included studies.
Characteristics and SIGN 50 score of included reviews grouped by TSR component
| Sun et al. [ | 3,916 subjects with chronic headache (migraine, tension-type or both) | electro | sham, pharmacologic, physiological, CAM | headache frequency/intensity, response rate | 31(31) RCTs | Positive | ++ |
| Linde et al. [ | 1,151 subjects with migraine and tension-type headaches | traditional Chinese | no treatment, sham, pharmacologic, physiotherapy | headache diary, number of migraine days, migraine hours, frequency/duration of headache attack, headache severity, amount and type of rescue medication, nausea and vomiting frequency, pain intensity, number of pain days | 22(22) RCTs | Positive | ++ |
| Linde et al. [ | 2,317 subjects with episodic and/or chronic tension-type headache | traditional Chinese | no treatment, sham, pharmacologic, physiological | analgesic usage, CGI, headache frequency/intensity/duration/location, global patient rating, PDI, VAS, CPG | 11(11) RCTs | Positive | ++ |
| Melchart et al. [ | (ND) subjects with recurrent headaches (tension-type, migraine, various) | manual, ear | sham, pharmacologic, physiological, no treatment, behavioral/psychosocial | headache attack frequency, global assessment of headache, number of days with headache, pain intensity, VAS | 20(22) RCTsa | Positive, Poor methods | ++ |
| Granato et al. [ | 2,317 subjects with episodic or chronic tension-type headaches | manual | no treatment, sham, physiotherapy, CAM | frequency of analgesic use, number of headache days, VAS | 11(11) RCTs | Positive | + |
| White et al. [ | 2,362 subjects with knee pain | manual, electro | sham, behavioral/psychosocial, no treatment, pharmacologic | WOMAC, pain scales | 13(13) RCTs | Positive | ++ |
| Kwon et al. [ | 1,891 subjects with peripheral joint osteoarthritis | manual, electro | no treatment, sham, behavioral/psychosocial, physiotherapy, pharmacologic | VAS, WOMAC, MPQ, NRS, TUGT, HSS knee function scale, walking/climbing stairs time, starting pain, night pain, walking pain, pain descending stairs, pain threshold, Lysholm Score, PGA, present pain intensity, stiffness, active knee flexion, passive range of movement, total pain, effective rate, recurrence rate, Lequesne indices | 18(18) RCTs | Positive | ++ |
| Manheimer et al. [ | 176 subjects with low back pain | Western | sham, physiotherapy, no treatment, acupressure, pharmacologic | VAS, drug use, fit for work score, global score, physician assessment of functionality | 4(33) RCTsb | Positive | ++ |
| Fu et al. [ | 7,173 subjects with neck pain | manual, electro | sham, no treatment, physiotherapy, CAM | MPQ, NDI, PDI, ROM, self-reported pain, VAS | 14(14) RCTs | Positive | ++ |
| Ezzo et al. [ | 393 subjects with knee osteoarthritis | electro, manual | sham, no treatment, physiotherapy | pain, patient global assessment, physical function | 7(7) RCTs and quasi-RCTs | Positive | ++ |
| Wang et al. [ | 536 subjects with rheumatoid arthritis | manual, electro | sham, pharmacologic | CRP, DAS28, duration of morning stiffness, ESR, GHQ, HAQ, SJC, VAS | 8(8) RCTs | Inconclusive/Mixed | ++ |
| Jung et al. [ | 134 subjects with temporomandibular joint disorders | manual | sham | MO, NRS, muscle tenderness, VAS | 6(7) RCTsa | Inconclusive/Mixed | ++ |
| Manheimer et al. [ | 3,498 subjects with osteoarthritis of the knee and/or hip | manual | sham, no treatment, other | WOMAC | 16(16) RCTs | Inconclusive/Mixed | ++ |
| La Touche et al. [ | 401 subjects with temporomandibular disorders | manual, electro | no treatment, sham | ADL, Anamnestic Index, Anamnestic Questionnaire, articular sounds/stereostethoscope, CDS, distribution of pain, index for occlusal state, incisal and occlusal tooth wear, maximum interincisal opening, NRS, pain frequency, PPT, subjective dysfunction score, VAS | 8(8) RCTs | Positive, Poor methods | ++ |
| Cho et al. [ | 808 subjects with temporomandibular disorders | manual, electro | sham, no treatment, pharmacologic, physiotherapy | clinical dysfunction scores, NAS, ROM, sounds/locking/deviation in opening of mouth, tenderness, presence/absence of a headache, overall improvement, VAS | 14(14) RCTs | Inconclusive/Mixed, Poor methods | ++ |
| Lee et al. [ | 606 subjects with rheumatoid arthritis | manual | sham, pharmacologic | ACR20, CRP, DAS, ESR, GHQ, HAQ, VAS, total effective rate, pain reduction, swelling index, number of swollen joints | 8(8) RCTs | Inconclusive/Mixed, Poor methods | ++ |
| Sim et al. [ | 442 subjects with carpal tunnel syndrome | manual, laser | sham, pharmacologic, CAM | CMAP, D4MNSCV, D4UNSCV, DML, DSL, GSS, MNCV, NCS, night pain, parethesia, responder rate, SNAP, SSS, W-P SNCV | 6(6) RCTs | Inconclusive/Mixed, Poor methods | ++ |
| Liu et al. [ | 506 subjects with trigeminal neuralgia | manual, electro | pharmacologic | cure rates | 12(12) RCTs | Inconclusive/Mixed, Poor methods | ++ |
| Langhorst et al. [ | 385 subjects with fibromyalgia syndrome | manual, electro | sham | FIQ, MPQ, VAS | 7(7) RCTs | Inconclusive/Mixed, Poor methods | ++ |
| Zhu et al. [ | 67 subjects with endometriosis | ear | CAM | dysmenorrhea score, therapeutic effect | 1(1) RCT | Negative, Poor methods | ++ |
| van Tulder et al. [ | 542 subjects with chronic lower back pain | manual, electro | sham, no treatment, pharmacologic | ADL, global improvement, Lasoque test, pain score, Schober Test, VAS | 11(11) RCTs | Negative, Poor methods | ++ |
| ter Riet et al. [ | (ND) subjects with chronic pain | manual | sham, pharmacologic, acupuncture | ND | 51(51) CCTs | Negative, Poor methods | ++ |
| Mayhew et al. [ | 166 subjects with fibromyalgia | traditional Chinese, electro | sham, no treatment, other | analgesics usage, dolorimetry of tender and control points, FIQ, morning stiffness, MPI, regional pain score, VAS | 5(5) RCTs | Negative, Poor methods | ++ |
| Porter et al. [ | 486 subjects with fibromyalgia | electro, manual | sham, no treatment, pharmacologic | physical, psychological and quality of life outcomes | 7(7) RCTs, 2(2) CCTs | Positive | + |
| Ernst et al. [ | (ND) subjects with chronic pain | ND | manual, electro, ear | ND | 30(30) SRs | Positive | + |
| White et al. [ | 2,362 subjects with osteoarthritis of the knee | electro, manual | sham, no treatment, physiologic, pharmacologic | NRS, PPI, VAS, WOMAC | 13(13) RCTs | Positive | + |
| La Touche et al. [ | 83 subjects with temporomandibular disorders | manual | sham | electronic axiography, incisor opening and lateral movement, manual palpitation, NRS, pain distribution, pressure algometer, temporomandibular joint sounds/stereo-stethoscope, VAS | 4(4)RCTs | Inconclusive/Mixed | + |
| Ernst [ | 437 subjects with osteoarthritis | manual, electro | sham, no treatment, pharmacologic, physiotherapy | analgesic usage, functioning, knee pain threshold, self-reported pain ratings, subjective improvement and ROM, tenderness, VAS | 13(13) RCTs | Inconclusive/Mixed | + |
| Manheimer et al. [ | 1,154 subjects with osteoarthritis | manual, electro | sham, no treatment | WOMAC | 11(11) RCTs | Inconclusive/Mixed | + |
| Casimiro et al. [ | 84 subjects with rheumatoid arthritis | manual, electro | sham, pharmacologic | analgesic usage, CRP, ESR, pain reduction, number of swollen/tender joints, VAS | 2(2) RCTs | Inconclusive/Mixed, Poor methods | + |
| Cho et al. [ | 1,062 subjects with alcohol dependence | ear, ear electro | no treatment, sham, pharmacologic, non-pharmacologic | abstinent rate, alcohol usage, AWSS, breath analyzer, CIWA, completion rates, relapse rates | 10(11) RCTsa | Inconclusive/Mixed, moor Methods | ++ |
| Gates et al. [ | 1,433 subjects with cocaine or crack dependence | ear | sham, no treatment | ASI, cocaine use, HCCS, urine toxicology | 7(7) RCTs | Negative, Poor methods | ++ |
| White et al. [ | 3,486 subjects with tobacco addiction | manual, electro | sham, no treatment, behavioral/psychosocial, pharmacologic | complete smoking cessation | 14(14) RCTs | Negative, Poor methods | ++ |
| D'Alberto et al. [ | 1,356 subjects with cocaine abuse or dependence | ear | sham, CAM | CCQ, urine toxicology | 6(6) RCTs | Inconclusive/Mixed | + |
| White et al. [ | 1,433 subjects with smoking addiction | ear, electro | behavioral/psychosocial, pharmacologic, no treatment, acupuncture, CAM | quit rates | 13(13) RCTs | Inconclusive/Mixed | + |
| ter Riet et al. [ | (ND) subjects addicted to cigarette smoking, heroin, or alcohol | manual, electro | ND | acupuncture effectiveness | 22(22) CCTs | Negative | + |
| Mills et al. [ | 1,747 subjects with cocaine addiction | ear | CAM, pharmacologic, behavioral/psychosocial | ASI, frequency/amount of cocaine use, HCCS, HDIRS, self-reported effectiveness, treatment effects, urine assays | 9(9) RCTs | Negative | + |
| Cao et al. [ | 3,811 subjects with insomnia | rolling, scalp, ear, abdominal | no treatment, CAM, sham, pharmacologic | duration and quality of sleep, MQ, PFS, PSQI, SDRS, sleep quality, SSDS, SRSS, VAS | 46(46) RCTs | Positive | ++ |
| Chen et al. [ | 673 subjects with insomnia | ear | no treatment, sham, pharmacologic | actigraphic monitoring, ISI, MQ, PSQI, sleeping hours | 6(6) RCTs | Inconclusive/Mixed | ++ |
| Yeung et al. [ | 1,956 subjects with insomnia | manual | sham, no treatment, pharmacologic | NRS, MQ, ISI, AIS, PSQI, SDRS, SSDS, PSG, wrist actigraph monitoring, overnight polysomnogram, VAS | 20(20) RCTs | Inconclusive/Mixed | ++ |
| Huang et al. [ | 1,355 subjects with insomnia | manual, ear, intradermal, rolling | sham, pharmacologic, education | AIS, ISI, PSQI, PFS, sleep diary, sleep time, wrist actigraph monitoring | 2(3) RCTs, 8(9) CCTs, 18(18) case seriesa | Positive, Poor methods | ++ |
| Cheuk et al. [ | 300 subjects with insomnia | electro, traditional Chinese, contemporary | no treatment, sham | self-rated insomnia scale, sleep disturbance on numerical scale, ISI, AIS, MQ, actigraphy monitoring | 4(7) RCTsa | Positive, Poor methods | ++ |
| Lee et al. [ | 842 subjects with insomnia | ear (needle, SV seeds taping, magnetic pearls) | sham, no treatment, pharmacologic | NST, Pittsburgh Sleep Diary, sleep efficiency, sleep quality, Karolinska Sleep Diary, 4-point Sleep Score, self-satisfaction scale | 10(10) RCTs | Inconclusive/Mixed, Poor methods | + |
| Zhang et al. [ | 1,680 subjects with MDD and PSD | manual, electro, ear | sham, no treatment, pharmacologic | HAM-D | 35(35) RCTs | Positive | ++ |
| Fan et al. [ | 2,757 subjects with depression or depressive disorders | manual | sham, pharmacologic | CGI, DSI, efficacy rate, HAM-D, SCL-90, SDS | 19(20) RCTsa | Positive | ++ |
| Mukaino et al. [ | 509 subjects with depression | manual, electro | no treatment, sham, pharmacologic | BRMS, CGI, HRSD | 7(7) RCTs | Inconclusive/Mixed | ++ |
| Wang et al. [ | 447 subjects with major depression or depressive neurosis | manual, electro | sham | HAM-D | 7(8) RCTsa | Inconclusive/Mixed, Poor methods | ++ |
| Smith et al. [ | 2,782 subjects with depression | abdominal, manual | sham, no treatment, pharmacologic | assessment of improvement, BDI, CGI, cure rates, HAM-D, HRSD, medication usage, Melancholia Scale, remission rates | 29(30) RCTsa | Inconclusive/Mixed, Poor methods | ++ |
| Leo et al. [ | 666 subjects with depression | verum, manual, ear, traditional Chinese, electro | no treatment, sham, CAM | BDI, CES-D, CGI, HAM-D | 9(9) RCTs | Inconclusive/Mixed | + |
| Pilkington et al. [ | 1,201 subjects with anxiety or an anxiety disorder | traditional Chinese, Western medical, ear, electro | sham, behavioral/psychosocial, pharmacologic | anesthesia dose, CGI, cure rates, HAM-A, MMPI, MYPAS, patient/observer assessment of anxiety, STAI, VAS, X-1 | 8(10) RCTs, 2(2) CCTsa | Positive | ++ |
| Zhao et al. [ | 960 subjects with vascular dementia | manual, electro, targets, ear | sham, pharmacologic | ADL, FAQ, HDS, MMSE-R, overall function | 9(10) RCT, 1(1) quasi- RCTa | Inconclusive/Mixed, Poor methods | ++ |
| Wang et al. [ | 1,826 participants with chronic fatigue syndrome | manual, electro | pharmacologic, CAM | improvement in chronic fatigue symptoms, FAI, SCL-90, CFIDS Disability Scale | 22(27) Clinical Trials, 9(13) RCTsa | Positive, Poor methods | |
aSome studies included in the reviews were excluded because they did not utilize manual acupuncture at recognized acupuncture points (that is, laser acupuncture, acupressure, needling of trigger points); bnumber of chronic pain studies may actually be higher; review only reported number of chronic pain studies not combined in meta-analysis instead of total number of chronic pain studies. Acu, acupuncture; AWSS, Alcohol-Withdrawal Syndrome Scale; ACR20, American College of Rheumatology Criteria; ADL, Activities of Daily Living; ASI, Addiction Severity Index; AIS, Athens Insomnia Index; BDI, Beck Depression Inventory; BRMS, Beck Melancholia Scale; CCT; controlled clinical trial; CCQ, Cocaine Craving Questionnaire; CCS, clinical case series; CDS, Clinical Dysfunction Score; CIWA, Clinical Institute Withdrawal Assessment; CES-D, Center for Epidemiological Study of Depression; CFIDS Disability Scale, Chronic Fatigue/Immune Dysfunction Syndrome Disability Scale; CPG, von Korff Chronic Pain Grading Scale; CGI, clinical global impression; CMAP, compound muscle action potential; CRP, C-reactive protein; D4MNSCV, 4th digit median nerve sensory nerve conduction velocity; D4UNSCV, 4th digit ulnar nerve sensory nerve conduction velocity; DAS, Disease Assessment Scale; DAS28, Disease Activity Scale in 28 Joints; DML, distal motor latency; DSI, Depression Status Inventory; DSL, Distal Sensory Latency; ESR, erythrocyte sedimentation rate; FAI, Fatigue Assessment Instrument; FAQ, Functional Activities Survey; FIQ, Fibromyalgia Impact Questionnaire; GHQ, General Health Questionnaire; GSS, Global Symptom Score; HDIRS, Halikas Drug Impairment Rating Scale; HAM-A, Hamilton Anxiety Scale; HAM-D, Hamilton Depression Rating Scale; HAQ, Health Assessment Questionnaire; HDS, Hasegawa Dementia Scale; HRSD, Hamilton Rating Scale for Depression; HSS, Hospital for Special Surgery; ISI, Index of Severity of Insomnia; JOA, Japanese Orthopedic Association Measure; MDD, Major Depressive Disorder; MMPI. Minnesota Multiphasic Personality Inventory; MMSE, Mini Mental State Examination; MNCV, motor nerve conduction velocity; MPI, Multidisciplinary Pain Inventory; MPQ, McGill Pain Questionnaire; MQ, Morning Questionnaire; MYPAS, Modified Yale Preoperative Anxiety Scale; NCS, Nerve Conduction Studies; ND, not described; NDI, Neck Disability Index; NAS, Numerical Analog Scale; NRS, Numeric Rating Scale; NST, nocturnal sleep time; ODI, Oswestry Disability Index; PDI, Pain Disability Index; PGA, Patient Global Assessment; PFS, Piper Fatigue Scale; PPI, Present Pain Index; PPT, pressure pain threshold; PSD, post-stroke depression; PSG, polysomnography; PSQI, Pittsburgh Sleep Quality Index; RCT, randomized controlled trial; ROM, range of motion; RDS, Roland Disability Score; SCL-90, Symptom Checklist-90; SDRS, Sleep Dysfunction Rating Scale; SDS, Self-rating Depression Scale; SJC, swollen joint count; SNAP, sensory nerve action potential; SRSS, Self-Rating Sleep Scale; SSDS, Self-Rating Sleep Dysfunction Scale; SSS, Symptom Severity Score; STAI, State-Trait Anxiety Inventory; TUGT, Timed Up and Go Test; VAS, Visual Analogue Scale; WOMAC, Western Ontario MacMaster Osteoarthritis Index; W-P SNCV, Wrist Palm Sensory Nerve Conduction Velocity.
Timed Up and Go Test; VAS, Visual Analogue Scale; WOMAC, Western Ontario MacMaster Osteoarthritis Index; W-P SNCV, Wrist Palm Sensory Nerve Conduction Velocity.
TSR GRADE table: quality in the overall literature pool by TSR components for acupuncture
| Chronic pain | 25 | 163 (12,675)a | Acupuncture promising, but no conclusions yet | +1c | weak recommendation in favor |
| Sleep disturbance | 6 | 83 (9,623)b | Acupuncture promising, but no conclusions yet | +1c | weak recommendation in favor |
| Depression | 6 | 73 (9,986) | Acupuncture promising, but no conclusions yet | 0c | weak recommendation in favor |
| Headache | 5 | 53 (8,274)b | Acupuncture shown to be effective | 0c | weak recommendation in favor |
| Anxiety | 1 | 10 (1,201) | Acupuncture promising, but no conclusions yet | 0 | weak recommendation in favor |
| Substance abuse | 7 | 48 (7,433)b | Acupuncture shown to be not effective | +1c | weak recommendation against |
| Cognitive function | 1 | 10 (960) | Unable to interpret/contradictory results | N/Ac | no recommendation |
| Fatigue | 1 | 31 (1,826) | Unable to interpret/contradictory results | +1 | no recommendation |
NOTE: Studies included within each review were de-duplicated. Because there was some discrepancy between reviews in how they reported their total number of participants, it is possible that the number of participants is slightly inaccurate; for purposes of this review, all studies were included as reported in each review; anumber of participants not described in two studies; bnumber of participants not described in one study; cstudies that did not report on adverse events were not included in the safety grade.
There are three major domains that comprise the core of the modified GRADE methodology: 1) Confidence in the results was categorized into the following groups using pre-defined criteria: (1) Acupuncture shown to be effective: the majority of the results are of high quality and all show positive results; or there is a most recent largest review showing positive results of highest quality; (2) Acupuncture promising, but no conclusions yet: mix of positive and inconclusive results, but no negative results found among the reviews; the majority of the reviews are of high quality; (3) Unable to interpret/contradictory results: low quality review or the majority of the studies have mixed/inconclusive results; or (4) Acupuncture shown to be not effective: the majority of the reviews report negative results. 2) Safety grade is dependent on the frequency and severity of adverse events and interactions. Safety is categorized into one of the following grades: +2: appears safe with infrequent adverse events and interactions; +1: appears relatively safe but with frequent but not serious adverse events and interactions; 0: safety not well understood or conflicting; -1: appears to have safety concerns that include infrequent but serious adverse events and/or interactions; or −2: has serious safety concerns that include frequent and serious adverse events and/or interactions. 3) Strength of the recommendation can be determined using the following categories and criteria: Strong recommendation in favor of or against: very certain that benefits do, or do not, outweigh risks and burdens; No recommendation: no recommendations can be made; or Weak recommendation in favor of or against: benefits and risks and burdens are finely balanced, or appreciable uncertainty exists about the magnitude of benefits and risks.
STRICTA analysis
| Acupuncture rationale | 6/6 | 24/26 | 7/7 | 6/6 | 6/6 | 1/1 | 1/1 | 1/1 | 96% |
| Details of needling | 4/6 | 18/26 | 5/7 | 4/6 | 3/6 | 1/1 | 0/1 | 1/1 | 67% |
| | | | | | | | | | |
| Number of treatment sessions | 4/6 | 16/26 | 4/7 | 5/6 | 4/6 | 1/1 | 0/1 | 1/1 | 65% |
| Frequency of treatments | 2/6 | 9/26 | 5/7 | 4/6 | 1/6 | 0/1 | 1/1 | 0/1 | 41% |
| Other components | 6/6 | 23/26 | 6/7 | 6/6 | 6/6 | 1/1 | 1/1 | 1/1 | 93% |
| Setting and context | 3/6 | 0/26 | 0/7 | 0/6 | 0/6 | 0/1 | 0/1 | 0/1 | 6% |
| Practitioner background | 4/6 | 1/26 | 3/7 | 0/6 | 1/6 | 0/1 | 0/1 | 0/1 | 2% |
| Control | 6/6 | 25/26 | 6/7 | 6/6 | 6/6 | 1/1 | 1/1 | 1/1 | 96% |
| Total | 73% | 56% | 64% | 65% | 56% | 63% | 50% | 63% | |
aTwo References [60,61] did not assess effectiveness of acupuncture and were excluded from outcomes assessment but included in STRICTA analysis.